name
Unicycive Therapeutics, Inc.homepage url
www.unicycive.comcountry
United Statesemployee count
14sector
Healthcareindustry
Biotechnologyrevenue
675K
Description
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
